Very Early PCSK9 Inhibition for Acute Myocardial Infarction

Abroad (travel likely)Recruiting

Conditions

Acute Myocardial Infarction (AMI)

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Zhongshan Hospital, Fudan University, Shanghai, Shanghai Municipality, China
Contact: Study coordinator (gao wei) · gao.wei1@zs-hospital.sh.cn · 13661959824

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Clinical Outcome and Cost-effectiveness of Reduced Noradrenaline by Using a Lower Blood Pressure Target in Patients With Cardiogenic Shock From Acute Myocardial Infarction

Cardiogenic Shock · Myocardial Infarction

Abroad (travel likely)RecruitingPHASE4

Amsterdam, Netherlands

Early Discharge Pathway Registry

Myocardial Infarction · ST Elevation Myocardial Infarction · Non-ST Elevation Myocardial Infarction

Abroad (travel likely)Recruiting

London, United Kingdom · London, United Kingdom

Long-term Follow-up Study Following the Approval of Hearticellgram-AMI Administration

Acute Myocardial Infarction

Abroad (travel likely)Recruiting

Seoul, South Korea

Assessment of an Early De-Escalation to a Low-potency Single Antiplatelet Therapy Guided by Genetics Versus a Systematic High-Potency Single Antiplatelet Therapy to Neutralize Bleeding Complications in Patients With High Bleeding Risk Beyond One Month After an Acute Coronary Syndrome

MYOCARDIAL INFARCTION

Abroad (travel likely)RecruitingPHASE3

Paris, France